CYP3A4 and Sepsis: Third, we detected drug interaction signals and found an increased risk of sepsis when ADCs were co-administrated with colony-stimulating factors, proton pump inhibitors, H2-receptor antagonists, and CYP3A4/5 strong inhibitors.